nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—Melatonin—CYP1B1—glaucoma	0.00203	1	CrCbGaD
Sumatriptan—Paraesthesia—Pilocarpine—glaucoma	0.000306	0.000333	CcSEcCtD
Sumatriptan—Asthenia—Bimatoprost—glaucoma	0.000306	0.000333	CcSEcCtD
Sumatriptan—Fatigue—Brinzolamide—glaucoma	0.000305	0.000333	CcSEcCtD
Sumatriptan—Angioedema—Clonidine—glaucoma	0.000304	0.000332	CcSEcCtD
Sumatriptan—Dyspnoea—Pilocarpine—glaucoma	0.000304	0.000331	CcSEcCtD
Sumatriptan—Pain—Brinzolamide—glaucoma	0.000303	0.00033	CcSEcCtD
Sumatriptan—Somnolence—Pilocarpine—glaucoma	0.000303	0.00033	CcSEcCtD
Sumatriptan—Depression—Timolol—glaucoma	0.000302	0.00033	CcSEcCtD
Sumatriptan—Angiopathy—Betaxolol—glaucoma	0.000302	0.00033	CcSEcCtD
Sumatriptan—Pruritus—Bimatoprost—glaucoma	0.000301	0.000329	CcSEcCtD
Sumatriptan—Immune system disorder—Betaxolol—glaucoma	0.000301	0.000328	CcSEcCtD
Sumatriptan—Diarrhoea—Apraclonidine—glaucoma	0.000301	0.000328	CcSEcCtD
Sumatriptan—Malaise—Clonidine—glaucoma	0.0003	0.000328	CcSEcCtD
Sumatriptan—Mediastinal disorder—Betaxolol—glaucoma	0.0003	0.000327	CcSEcCtD
Sumatriptan—Chills—Betaxolol—glaucoma	0.000299	0.000326	CcSEcCtD
Sumatriptan—Syncope—Clonidine—glaucoma	0.000299	0.000326	CcSEcCtD
Sumatriptan—Arrhythmia—Betaxolol—glaucoma	0.000298	0.000325	CcSEcCtD
Sumatriptan—Feeling abnormal—Dorzolamide—glaucoma	0.000297	0.000324	CcSEcCtD
Sumatriptan—Decreased appetite—Pilocarpine—glaucoma	0.000296	0.000323	CcSEcCtD
Sumatriptan—Feeling abnormal—Travoprost—glaucoma	0.000296	0.000322	CcSEcCtD
Sumatriptan—Conjunctivitis—Timolol—glaucoma	0.000295	0.000321	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Dorzolamide—glaucoma	0.000295	0.000321	CcSEcCtD
Sumatriptan—Palpitations—Clonidine—glaucoma	0.000294	0.000321	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000294	0.000321	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Travoprost—glaucoma	0.000293	0.00032	CcSEcCtD
Sumatriptan—Loss of consciousness—Clonidine—glaucoma	0.000293	0.000319	CcSEcCtD
Sumatriptan—Feeling abnormal—Brinzolamide—glaucoma	0.000292	0.000318	CcSEcCtD
Sumatriptan—Constipation—Pilocarpine—glaucoma	0.000291	0.000318	CcSEcCtD
Sumatriptan—Pain—Pilocarpine—glaucoma	0.000291	0.000318	CcSEcCtD
Sumatriptan—Cough—Clonidine—glaucoma	0.000291	0.000317	CcSEcCtD
Sumatriptan—Sweating—Timolol—glaucoma	0.000291	0.000317	CcSEcCtD
Sumatriptan—Dizziness—Apraclonidine—glaucoma	0.000291	0.000317	CcSEcCtD
Sumatriptan—Erythema—Betaxolol—glaucoma	0.00029	0.000316	CcSEcCtD
Sumatriptan—Urticaria—Dorzolamide—glaucoma	0.000286	0.000312	CcSEcCtD
Sumatriptan—Epistaxis—Timolol—glaucoma	0.000286	0.000312	CcSEcCtD
Sumatriptan—Abdominal pain—Dorzolamide—glaucoma	0.000285	0.000311	CcSEcCtD
Sumatriptan—Body temperature increased—Dorzolamide—glaucoma	0.000285	0.000311	CcSEcCtD
Sumatriptan—Sinusitis—Timolol—glaucoma	0.000284	0.00031	CcSEcCtD
Sumatriptan—Dysgeusia—Betaxolol—glaucoma	0.000284	0.00031	CcSEcCtD
Sumatriptan—Arthralgia—Clonidine—glaucoma	0.000284	0.000309	CcSEcCtD
Sumatriptan—Chest pain—Clonidine—glaucoma	0.000284	0.000309	CcSEcCtD
Sumatriptan—Abdominal pain—Travoprost—glaucoma	0.000284	0.000309	CcSEcCtD
Sumatriptan—Anxiety—Clonidine—glaucoma	0.000283	0.000308	CcSEcCtD
Sumatriptan—Asthenia—Acetazolamide—glaucoma	0.000282	0.000308	CcSEcCtD
Sumatriptan—Dizziness—Bimatoprost—glaucoma	0.000282	0.000307	CcSEcCtD
Sumatriptan—Urticaria—Brinzolamide—glaucoma	0.000281	0.000307	CcSEcCtD
Sumatriptan—Feeling abnormal—Pilocarpine—glaucoma	0.000281	0.000306	CcSEcCtD
Sumatriptan—Discomfort—Clonidine—glaucoma	0.00028	0.000306	CcSEcCtD
Sumatriptan—Vomiting—Apraclonidine—glaucoma	0.000279	0.000305	CcSEcCtD
Sumatriptan—Muscle spasms—Betaxolol—glaucoma	0.000279	0.000304	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Pilocarpine—glaucoma	0.000278	0.000304	CcSEcCtD
Sumatriptan—Hypersensitivity—Brimonidine—glaucoma	0.000278	0.000303	CcSEcCtD
Sumatriptan—Dry mouth—Clonidine—glaucoma	0.000277	0.000302	CcSEcCtD
Sumatriptan—Bradycardia—Timolol—glaucoma	0.000277	0.000302	CcSEcCtD
Sumatriptan—Dermatitis—Apraclonidine—glaucoma	0.000277	0.000302	CcSEcCtD
Sumatriptan—Headache—Apraclonidine—glaucoma	0.000275	0.0003	CcSEcCtD
Sumatriptan—Confusional state—Clonidine—glaucoma	0.000274	0.000299	CcSEcCtD
Sumatriptan—Oedema—Clonidine—glaucoma	0.000272	0.000297	CcSEcCtD
Sumatriptan—Tremor—Betaxolol—glaucoma	0.000272	0.000296	CcSEcCtD
Sumatriptan—Hallucination—Timolol—glaucoma	0.000271	0.000295	CcSEcCtD
Sumatriptan—Asthenia—Brimonidine—glaucoma	0.000271	0.000295	CcSEcCtD
Sumatriptan—Infection—Clonidine—glaucoma	0.00027	0.000295	CcSEcCtD
Sumatriptan—Body temperature increased—Pilocarpine—glaucoma	0.000269	0.000294	CcSEcCtD
Sumatriptan—Abdominal pain—Pilocarpine—glaucoma	0.000269	0.000294	CcSEcCtD
Sumatriptan—Ill-defined disorder—Betaxolol—glaucoma	0.000269	0.000293	CcSEcCtD
Sumatriptan—Diarrhoea—Acetazolamide—glaucoma	0.000269	0.000293	CcSEcCtD
Sumatriptan—Rash—Bimatoprost—glaucoma	0.000269	0.000293	CcSEcCtD
Sumatriptan—Dermatitis—Bimatoprost—glaucoma	0.000268	0.000293	CcSEcCtD
Sumatriptan—Anaemia—Betaxolol—glaucoma	0.000268	0.000292	CcSEcCtD
Sumatriptan—Shock—Clonidine—glaucoma	0.000268	0.000292	CcSEcCtD
Sumatriptan—Connective tissue disorder—Timolol—glaucoma	0.000268	0.000292	CcSEcCtD
Sumatriptan—Pruritus—Brimonidine—glaucoma	0.000267	0.000291	CcSEcCtD
Sumatriptan—Headache—Bimatoprost—glaucoma	0.000267	0.000291	CcSEcCtD
Sumatriptan—Nervous system disorder—Clonidine—glaucoma	0.000267	0.000291	CcSEcCtD
Sumatriptan—Thrombocytopenia—Clonidine—glaucoma	0.000266	0.00029	CcSEcCtD
Sumatriptan—Hypersensitivity—Dorzolamide—glaucoma	0.000265	0.000289	CcSEcCtD
Sumatriptan—Tachycardia—Clonidine—glaucoma	0.000265	0.000289	CcSEcCtD
Sumatriptan—Hypersensitivity—Travoprost—glaucoma	0.000264	0.000288	CcSEcCtD
Sumatriptan—Skin disorder—Clonidine—glaucoma	0.000264	0.000288	CcSEcCtD
Sumatriptan—Hyperhidrosis—Clonidine—glaucoma	0.000263	0.000287	CcSEcCtD
Sumatriptan—Visual impairment—Timolol—glaucoma	0.000262	0.000286	CcSEcCtD
Sumatriptan—Malaise—Betaxolol—glaucoma	0.000262	0.000285	CcSEcCtD
Sumatriptan—Nausea—Apraclonidine—glaucoma	0.000261	0.000285	CcSEcCtD
Sumatriptan—Hypersensitivity—Brinzolamide—glaucoma	0.000261	0.000285	CcSEcCtD
Sumatriptan—Vertigo—Betaxolol—glaucoma	0.000261	0.000284	CcSEcCtD
Sumatriptan—Syncope—Betaxolol—glaucoma	0.00026	0.000284	CcSEcCtD
Sumatriptan—Dizziness—Acetazolamide—glaucoma	0.00026	0.000283	CcSEcCtD
Sumatriptan—Asthenia—Dorzolamide—glaucoma	0.000259	0.000282	CcSEcCtD
Sumatriptan—Asthenia—Travoprost—glaucoma	0.000257	0.000281	CcSEcCtD
Sumatriptan—Palpitations—Betaxolol—glaucoma	0.000256	0.00028	CcSEcCtD
Sumatriptan—Pruritus—Dorzolamide—glaucoma	0.000255	0.000278	CcSEcCtD
Sumatriptan—Loss of consciousness—Betaxolol—glaucoma	0.000255	0.000278	CcSEcCtD
Sumatriptan—Eye disorder—Timolol—glaucoma	0.000254	0.000277	CcSEcCtD
Sumatriptan—Asthenia—Brinzolamide—glaucoma	0.000254	0.000277	CcSEcCtD
Sumatriptan—Hypotension—Clonidine—glaucoma	0.000254	0.000277	CcSEcCtD
Sumatriptan—Pruritus—Travoprost—glaucoma	0.000254	0.000277	CcSEcCtD
Sumatriptan—Tinnitus—Timolol—glaucoma	0.000254	0.000277	CcSEcCtD
Sumatriptan—Cough—Betaxolol—glaucoma	0.000253	0.000276	CcSEcCtD
Sumatriptan—Nausea—Bimatoprost—glaucoma	0.000253	0.000276	CcSEcCtD
Sumatriptan—Hypersensitivity—Pilocarpine—glaucoma	0.000251	0.000274	CcSEcCtD
Sumatriptan—Pruritus—Brinzolamide—glaucoma	0.000251	0.000273	CcSEcCtD
Sumatriptan—Vomiting—Acetazolamide—glaucoma	0.00025	0.000273	CcSEcCtD
Sumatriptan—Dizziness—Brimonidine—glaucoma	0.00025	0.000272	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Clonidine—glaucoma	0.000248	0.00027	CcSEcCtD
Sumatriptan—Angiopathy—Timolol—glaucoma	0.000247	0.000269	CcSEcCtD
Sumatriptan—Myalgia—Betaxolol—glaucoma	0.000247	0.000269	CcSEcCtD
Sumatriptan—Arthralgia—Betaxolol—glaucoma	0.000247	0.000269	CcSEcCtD
Sumatriptan—Chest pain—Betaxolol—glaucoma	0.000247	0.000269	CcSEcCtD
Sumatriptan—Diarrhoea—Dorzolamide—glaucoma	0.000247	0.000269	CcSEcCtD
Sumatriptan—Headache—Acetazolamide—glaucoma	0.000246	0.000269	CcSEcCtD
Sumatriptan—Anxiety—Betaxolol—glaucoma	0.000246	0.000268	CcSEcCtD
Sumatriptan—Immune system disorder—Timolol—glaucoma	0.000246	0.000268	CcSEcCtD
Sumatriptan—Diarrhoea—Travoprost—glaucoma	0.000245	0.000268	CcSEcCtD
Sumatriptan—Mediastinal disorder—Timolol—glaucoma	0.000245	0.000268	CcSEcCtD
Sumatriptan—Asthenia—Pilocarpine—glaucoma	0.000244	0.000266	CcSEcCtD
Sumatriptan—Paraesthesia—Clonidine—glaucoma	0.000244	0.000266	CcSEcCtD
Sumatriptan—Discomfort—Betaxolol—glaucoma	0.000244	0.000266	CcSEcCtD
Sumatriptan—Arrhythmia—Timolol—glaucoma	0.000243	0.000265	CcSEcCtD
Sumatriptan—Dyspnoea—Clonidine—glaucoma	0.000242	0.000264	CcSEcCtD
Sumatriptan—Diarrhoea—Brinzolamide—glaucoma	0.000242	0.000264	CcSEcCtD
Sumatriptan—Somnolence—Clonidine—glaucoma	0.000242	0.000264	CcSEcCtD
Sumatriptan—Dry mouth—Betaxolol—glaucoma	0.000242	0.000263	CcSEcCtD
Sumatriptan—Pruritus—Pilocarpine—glaucoma	0.000241	0.000263	CcSEcCtD
Sumatriptan—Confusional state—Betaxolol—glaucoma	0.000239	0.00026	CcSEcCtD
Sumatriptan—Dizziness—Dorzolamide—glaucoma	0.000238	0.00026	CcSEcCtD
Sumatriptan—Rash—Brimonidine—glaucoma	0.000238	0.000259	CcSEcCtD
Sumatriptan—Dermatitis—Brimonidine—glaucoma	0.000238	0.000259	CcSEcCtD
Sumatriptan—Dizziness—Travoprost—glaucoma	0.000237	0.000259	CcSEcCtD
Sumatriptan—Erythema—Timolol—glaucoma	0.000237	0.000258	CcSEcCtD
Sumatriptan—Oedema—Betaxolol—glaucoma	0.000237	0.000258	CcSEcCtD
Sumatriptan—Headache—Brimonidine—glaucoma	0.000236	0.000258	CcSEcCtD
Sumatriptan—Decreased appetite—Clonidine—glaucoma	0.000236	0.000258	CcSEcCtD
Sumatriptan—Infection—Betaxolol—glaucoma	0.000235	0.000256	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Clonidine—glaucoma	0.000235	0.000256	CcSEcCtD
Sumatriptan—Fatigue—Clonidine—glaucoma	0.000234	0.000256	CcSEcCtD
Sumatriptan—Dizziness—Brinzolamide—glaucoma	0.000234	0.000255	CcSEcCtD
Sumatriptan—Nausea—Acetazolamide—glaucoma	0.000234	0.000255	CcSEcCtD
Sumatriptan—Diarrhoea—Pilocarpine—glaucoma	0.000233	0.000254	CcSEcCtD
Sumatriptan—Shock—Betaxolol—glaucoma	0.000233	0.000254	CcSEcCtD
Sumatriptan—Pain—Clonidine—glaucoma	0.000233	0.000254	CcSEcCtD
Sumatriptan—Constipation—Clonidine—glaucoma	0.000233	0.000254	CcSEcCtD
Sumatriptan—Nervous system disorder—Betaxolol—glaucoma	0.000232	0.000253	CcSEcCtD
Sumatriptan—Dysgeusia—Timolol—glaucoma	0.000232	0.000253	CcSEcCtD
Sumatriptan—Thrombocytopenia—Betaxolol—glaucoma	0.000232	0.000253	CcSEcCtD
Sumatriptan—Tachycardia—Betaxolol—glaucoma	0.000231	0.000252	CcSEcCtD
Sumatriptan—Skin disorder—Betaxolol—glaucoma	0.00023	0.000251	CcSEcCtD
Sumatriptan—Vomiting—Dorzolamide—glaucoma	0.000229	0.00025	CcSEcCtD
Sumatriptan—Hyperhidrosis—Betaxolol—glaucoma	0.000229	0.00025	CcSEcCtD
Sumatriptan—Rash—Dorzolamide—glaucoma	0.000227	0.000248	CcSEcCtD
Sumatriptan—Dermatitis—Dorzolamide—glaucoma	0.000227	0.000248	CcSEcCtD
Sumatriptan—Rash—Travoprost—glaucoma	0.000226	0.000247	CcSEcCtD
Sumatriptan—Dermatitis—Travoprost—glaucoma	0.000226	0.000246	CcSEcCtD
Sumatriptan—Headache—Dorzolamide—glaucoma	0.000226	0.000246	CcSEcCtD
Sumatriptan—Vomiting—Brinzolamide—glaucoma	0.000225	0.000246	CcSEcCtD
Sumatriptan—Dizziness—Pilocarpine—glaucoma	0.000225	0.000246	CcSEcCtD
Sumatriptan—Headache—Travoprost—glaucoma	0.000225	0.000245	CcSEcCtD
Sumatriptan—Nausea—Brimonidine—glaucoma	0.000224	0.000244	CcSEcCtD
Sumatriptan—Feeling abnormal—Clonidine—glaucoma	0.000224	0.000244	CcSEcCtD
Sumatriptan—Rash—Brinzolamide—glaucoma	0.000223	0.000244	CcSEcCtD
Sumatriptan—Dermatitis—Brinzolamide—glaucoma	0.000223	0.000243	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Clonidine—glaucoma	0.000222	0.000242	CcSEcCtD
Sumatriptan—Headache—Brinzolamide—glaucoma	0.000222	0.000242	CcSEcCtD
Sumatriptan—Hypotension—Betaxolol—glaucoma	0.000221	0.000241	CcSEcCtD
Sumatriptan—Angioedema—Timolol—glaucoma	0.000217	0.000236	CcSEcCtD
Sumatriptan—Vomiting—Pilocarpine—glaucoma	0.000217	0.000236	CcSEcCtD
Sumatriptan—Urticaria—Clonidine—glaucoma	0.000216	0.000236	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000216	0.000235	CcSEcCtD
Sumatriptan—Abdominal pain—Clonidine—glaucoma	0.000215	0.000234	CcSEcCtD
Sumatriptan—Body temperature increased—Clonidine—glaucoma	0.000215	0.000234	CcSEcCtD
Sumatriptan—Rash—Pilocarpine—glaucoma	0.000215	0.000234	CcSEcCtD
Sumatriptan—Dermatitis—Pilocarpine—glaucoma	0.000214	0.000234	CcSEcCtD
Sumatriptan—Nausea—Dorzolamide—glaucoma	0.000214	0.000233	CcSEcCtD
Sumatriptan—Headache—Pilocarpine—glaucoma	0.000213	0.000233	CcSEcCtD
Sumatriptan—Nausea—Travoprost—glaucoma	0.000213	0.000232	CcSEcCtD
Sumatriptan—Vertigo—Timolol—glaucoma	0.000213	0.000232	CcSEcCtD
Sumatriptan—Paraesthesia—Betaxolol—glaucoma	0.000213	0.000232	CcSEcCtD
Sumatriptan—Syncope—Timolol—glaucoma	0.000213	0.000232	CcSEcCtD
Sumatriptan—Dyspnoea—Betaxolol—glaucoma	0.000211	0.00023	CcSEcCtD
Sumatriptan—Nausea—Brinzolamide—glaucoma	0.00021	0.000229	CcSEcCtD
Sumatriptan—Palpitations—Timolol—glaucoma	0.000209	0.000228	CcSEcCtD
Sumatriptan—Loss of consciousness—Timolol—glaucoma	0.000208	0.000227	CcSEcCtD
Sumatriptan—Cough—Timolol—glaucoma	0.000207	0.000225	CcSEcCtD
Sumatriptan—Decreased appetite—Betaxolol—glaucoma	0.000206	0.000224	CcSEcCtD
Sumatriptan—Hypertension—Timolol—glaucoma	0.000205	0.000223	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Betaxolol—glaucoma	0.000204	0.000223	CcSEcCtD
Sumatriptan—Fatigue—Betaxolol—glaucoma	0.000204	0.000223	CcSEcCtD
Sumatriptan—Pain—Betaxolol—glaucoma	0.000202	0.000221	CcSEcCtD
Sumatriptan—Constipation—Betaxolol—glaucoma	0.000202	0.000221	CcSEcCtD
Sumatriptan—Nausea—Pilocarpine—glaucoma	0.000202	0.000221	CcSEcCtD
Sumatriptan—Arthralgia—Timolol—glaucoma	0.000202	0.00022	CcSEcCtD
Sumatriptan—Chest pain—Timolol—glaucoma	0.000202	0.00022	CcSEcCtD
Sumatriptan—Myalgia—Timolol—glaucoma	0.000202	0.00022	CcSEcCtD
Sumatriptan—Anxiety—Timolol—glaucoma	0.000201	0.000219	CcSEcCtD
Sumatriptan—Hypersensitivity—Clonidine—glaucoma	0.0002	0.000218	CcSEcCtD
Sumatriptan—Discomfort—Timolol—glaucoma	0.000199	0.000217	CcSEcCtD
Sumatriptan—Dry mouth—Timolol—glaucoma	0.000197	0.000215	CcSEcCtD
Sumatriptan—Asthenia—Clonidine—glaucoma	0.000195	0.000213	CcSEcCtD
Sumatriptan—Feeling abnormal—Betaxolol—glaucoma	0.000195	0.000213	CcSEcCtD
Sumatriptan—Confusional state—Timolol—glaucoma	0.000195	0.000213	CcSEcCtD
Sumatriptan—Anaphylactic shock—Timolol—glaucoma	0.000193	0.000211	CcSEcCtD
Sumatriptan—Oedema—Timolol—glaucoma	0.000193	0.000211	CcSEcCtD
Sumatriptan—Pruritus—Clonidine—glaucoma	0.000192	0.00021	CcSEcCtD
Sumatriptan—Infection—Timolol—glaucoma	0.000192	0.00021	CcSEcCtD
Sumatriptan—Shock—Timolol—glaucoma	0.00019	0.000207	CcSEcCtD
Sumatriptan—Nervous system disorder—Timolol—glaucoma	0.00019	0.000207	CcSEcCtD
Sumatriptan—Urticaria—Betaxolol—glaucoma	0.000188	0.000205	CcSEcCtD
Sumatriptan—Skin disorder—Timolol—glaucoma	0.000188	0.000205	CcSEcCtD
Sumatriptan—Body temperature increased—Betaxolol—glaucoma	0.000187	0.000204	CcSEcCtD
Sumatriptan—Hyperhidrosis—Timolol—glaucoma	0.000187	0.000204	CcSEcCtD
Sumatriptan—Diarrhoea—Clonidine—glaucoma	0.000186	0.000203	CcSEcCtD
Sumatriptan—Hypotension—Timolol—glaucoma	0.000181	0.000197	CcSEcCtD
Sumatriptan—Dizziness—Clonidine—glaucoma	0.00018	0.000196	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Timolol—glaucoma	0.000176	0.000192	CcSEcCtD
Sumatriptan—Hypersensitivity—Betaxolol—glaucoma	0.000174	0.00019	CcSEcCtD
Sumatriptan—Paraesthesia—Timolol—glaucoma	0.000174	0.000189	CcSEcCtD
Sumatriptan—Vomiting—Clonidine—glaucoma	0.000173	0.000189	CcSEcCtD
Sumatriptan—Dyspnoea—Timolol—glaucoma	0.000172	0.000188	CcSEcCtD
Sumatriptan—Somnolence—Timolol—glaucoma	0.000172	0.000187	CcSEcCtD
Sumatriptan—Rash—Clonidine—glaucoma	0.000171	0.000187	CcSEcCtD
Sumatriptan—Dermatitis—Clonidine—glaucoma	0.000171	0.000187	CcSEcCtD
Sumatriptan—Headache—Clonidine—glaucoma	0.00017	0.000186	CcSEcCtD
Sumatriptan—Asthenia—Betaxolol—glaucoma	0.00017	0.000185	CcSEcCtD
Sumatriptan—Decreased appetite—Timolol—glaucoma	0.000168	0.000183	CcSEcCtD
Sumatriptan—Pruritus—Betaxolol—glaucoma	0.000167	0.000183	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Timolol—glaucoma	0.000167	0.000182	CcSEcCtD
Sumatriptan—Fatigue—Timolol—glaucoma	0.000167	0.000182	CcSEcCtD
Sumatriptan—Pain—Timolol—glaucoma	0.000165	0.00018	CcSEcCtD
Sumatriptan—Diarrhoea—Betaxolol—glaucoma	0.000162	0.000177	CcSEcCtD
Sumatriptan—Nausea—Clonidine—glaucoma	0.000162	0.000176	CcSEcCtD
Sumatriptan—Feeling abnormal—Timolol—glaucoma	0.000159	0.000174	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Timolol—glaucoma	0.000158	0.000172	CcSEcCtD
Sumatriptan—Dizziness—Betaxolol—glaucoma	0.000157	0.000171	CcSEcCtD
Sumatriptan—Urticaria—Timolol—glaucoma	0.000154	0.000168	CcSEcCtD
Sumatriptan—Abdominal pain—Timolol—glaucoma	0.000153	0.000167	CcSEcCtD
Sumatriptan—Body temperature increased—Timolol—glaucoma	0.000153	0.000167	CcSEcCtD
Sumatriptan—Vomiting—Betaxolol—glaucoma	0.000151	0.000164	CcSEcCtD
Sumatriptan—Rash—Betaxolol—glaucoma	0.000149	0.000163	CcSEcCtD
Sumatriptan—Dermatitis—Betaxolol—glaucoma	0.000149	0.000163	CcSEcCtD
Sumatriptan—Headache—Betaxolol—glaucoma	0.000148	0.000162	CcSEcCtD
Sumatriptan—Hypersensitivity—Timolol—glaucoma	0.000142	0.000155	CcSEcCtD
Sumatriptan—Nausea—Betaxolol—glaucoma	0.000141	0.000153	CcSEcCtD
Sumatriptan—Asthenia—Timolol—glaucoma	0.000139	0.000151	CcSEcCtD
Sumatriptan—Pruritus—Timolol—glaucoma	0.000137	0.000149	CcSEcCtD
Sumatriptan—Diarrhoea—Timolol—glaucoma	0.000132	0.000144	CcSEcCtD
Sumatriptan—Dizziness—Timolol—glaucoma	0.000128	0.000139	CcSEcCtD
Sumatriptan—HTR1F—Signaling Pathways—NCK2—glaucoma	0.000123	0.00152	CbGpPWpGaD
Sumatriptan—Vomiting—Timolol—glaucoma	0.000123	0.000134	CcSEcCtD
Sumatriptan—HTR1A—G alpha (i) signalling events—C3—glaucoma	0.000123	0.00152	CbGpPWpGaD
Sumatriptan—Rash—Timolol—glaucoma	0.000122	0.000133	CcSEcCtD
Sumatriptan—Dermatitis—Timolol—glaucoma	0.000122	0.000133	CcSEcCtD
Sumatriptan—SLCO1A2—Metabolism—CA1—glaucoma	0.000122	0.0015	CbGpPWpGaD
Sumatriptan—Headache—Timolol—glaucoma	0.000121	0.000132	CcSEcCtD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000118	0.00146	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CTSA—glaucoma	0.000118	0.00146	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—OPN4—glaucoma	0.000115	0.00143	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PTGFR—glaucoma	0.000115	0.00143	CbGpPWpGaD
Sumatriptan—Nausea—Timolol—glaucoma	0.000115	0.000125	CcSEcCtD
Sumatriptan—HTR1D—GPCR ligand binding—EDN1—glaucoma	0.000114	0.00141	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—SMO—glaucoma	0.000113	0.0014	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—OPN4—glaucoma	0.000113	0.0014	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CA1—glaucoma	0.000113	0.00139	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000112	0.00138	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—EDN1—glaucoma	0.000112	0.00138	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CA2—glaucoma	0.000111	0.00137	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CTSA—glaucoma	0.000109	0.00135	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LRP12—glaucoma	0.000109	0.00135	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000109	0.00134	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000109	0.00134	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—C3—glaucoma	0.000108	0.00133	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HEYL—glaucoma	0.000107	0.00133	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NARFL—glaucoma	0.000107	0.00132	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CA5A—glaucoma	0.000107	0.00132	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HEYL—glaucoma	0.000105	0.0013	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HDAC9—glaucoma	0.000105	0.0013	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTGFR—glaucoma	0.000104	0.00129	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CA1—glaucoma	0.000104	0.00129	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CA2—glaucoma	0.000103	0.00127	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000102	0.00126	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTGFR—glaucoma	0.000102	0.00126	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—EDN1—glaucoma	0.000101	0.00125	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CTSA—glaucoma	0.000101	0.00125	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000101	0.00124	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—C3—glaucoma	9.96e-05	0.00123	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	9.81e-05	0.00121	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	9.76e-05	0.00121	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—C3—glaucoma	9.75e-05	0.00121	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CA1—glaucoma	9.63e-05	0.00119	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CA2—glaucoma	9.51e-05	0.00118	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	9.39e-05	0.00116	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	9.33e-05	0.00115	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CTSA—glaucoma	9.32e-05	0.00115	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.29e-05	0.00115	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.29e-05	0.00115	CbGpPWpGaD
Sumatriptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	9.26e-05	0.00114	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—EDN1—glaucoma	9.15e-05	0.00113	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—SMO—glaucoma	8.88e-05	0.0011	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CA2—glaucoma	8.81e-05	0.00109	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—C3—glaucoma	8.8e-05	0.00109	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	8.72e-05	0.00108	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—SMO—glaucoma	8.69e-05	0.00107	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—TNF—glaucoma	8.63e-05	0.00107	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—OPN4—glaucoma	8.61e-05	0.00107	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	8.57e-05	0.00106	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—VEGFA—glaucoma	8.56e-05	0.00106	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—EDN1—glaucoma	8.51e-05	0.00105	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SMO—glaucoma	8.2e-05	0.00101	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RPTOR—glaucoma	8.14e-05	0.00101	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—VEGFA—glaucoma	8.02e-05	0.000991	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HEYL—glaucoma	8.01e-05	0.00099	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—C3—glaucoma	7.99e-05	0.000988	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	7.99e-05	0.000987	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RPTOR—glaucoma	7.97e-05	0.000985	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NCK2—glaucoma	7.88e-05	0.000974	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—TXN—glaucoma	7.84e-05	0.000969	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTGFR—glaucoma	7.76e-05	0.000959	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NCK2—glaucoma	7.72e-05	0.000954	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—OPN4—glaucoma	7.56e-05	0.000935	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NTRK2—glaucoma	7.5e-05	0.000927	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—EDN1—glaucoma	7.47e-05	0.000923	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—C3—glaucoma	7.43e-05	0.000919	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—glaucoma	7.33e-05	0.000907	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—TXN—glaucoma	7.26e-05	0.000898	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.15e-05	0.000884	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.08e-05	0.000876	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HEYL—glaucoma	7.03e-05	0.000869	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—TNF—glaucoma	6.87e-05	0.000849	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	6.83e-05	0.000844	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTGFR—glaucoma	6.81e-05	0.000842	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HDAC9—glaucoma	6.7e-05	0.000828	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—TXN—glaucoma	6.7e-05	0.000828	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—SMO—glaucoma	6.62e-05	0.000819	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HDAC9—glaucoma	6.56e-05	0.000811	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—C3—glaucoma	6.52e-05	0.000807	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—EDN1—glaucoma	6.44e-05	0.000797	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NGFR—glaucoma	6.43e-05	0.000795	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	6.38e-05	0.000789	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—EDN1—glaucoma	6.31e-05	0.00078	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—TXN—glaucoma	6.2e-05	0.000767	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.11e-05	0.000756	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NTRK1—glaucoma	6.11e-05	0.000756	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTT1—glaucoma	6.08e-05	0.000751	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RPTOR—glaucoma	6.07e-05	0.00075	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.06e-05	0.000749	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NCK2—glaucoma	5.88e-05	0.000727	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EDN1—glaucoma	5.85e-05	0.000724	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—SMO—glaucoma	5.81e-05	0.000719	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EDN1—glaucoma	5.73e-05	0.000708	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CDKN2B—glaucoma	5.63e-05	0.000697	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTT1—glaucoma	5.63e-05	0.000696	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—C3—glaucoma	5.63e-05	0.000696	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—C3—glaucoma	5.51e-05	0.000682	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EDN1—glaucoma	5.41e-05	0.000668	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RPTOR—glaucoma	5.33e-05	0.000659	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SMO—glaucoma	5.24e-05	0.000648	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CA1—glaucoma	5.21e-05	0.000644	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTT1—glaucoma	5.2e-05	0.000642	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NCK2—glaucoma	5.16e-05	0.000638	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SMO—glaucoma	5.13e-05	0.000635	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—C3—glaucoma	5.11e-05	0.000632	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CTSA—glaucoma	5.04e-05	0.000623	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	5.02e-05	0.000621	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—C3—glaucoma	5.01e-05	0.000619	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HDAC9—glaucoma	5e-05	0.000618	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NGF—glaucoma	4.97e-05	0.000614	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.9e-05	0.000606	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ABCA1—glaucoma	4.84e-05	0.000599	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CYP1B1—glaucoma	4.84e-05	0.000599	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTT1—glaucoma	4.81e-05	0.000595	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—EDN1—glaucoma	4.81e-05	0.000594	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NTRK2—glaucoma	4.8e-05	0.000593	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CA2—glaucoma	4.76e-05	0.000589	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.76e-05	0.000588	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—C3—glaucoma	4.72e-05	0.000584	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NTRK2—glaucoma	4.7e-05	0.000581	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—TP53—glaucoma	4.64e-05	0.000573	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ABCA1—glaucoma	4.49e-05	0.000555	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CYP1B1—glaucoma	4.49e-05	0.000555	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—APOE—glaucoma	4.4e-05	0.000544	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HDAC9—glaucoma	4.39e-05	0.000543	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EDN1—glaucoma	4.36e-05	0.00054	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CAV1—glaucoma	4.36e-05	0.000539	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—EDN1—glaucoma	4.22e-05	0.000522	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—C3—glaucoma	4.2e-05	0.000519	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.19e-05	0.000518	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—FN1—glaucoma	4.15e-05	0.000513	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ABCA1—glaucoma	4.14e-05	0.000512	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CYP1B1—glaucoma	4.14e-05	0.000512	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NGFR—glaucoma	4.11e-05	0.000509	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—BAD—glaucoma	4.1e-05	0.000507	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NGFR—glaucoma	4.03e-05	0.000498	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.96e-05	0.000489	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SMO—glaucoma	3.91e-05	0.000484	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NTRK1—glaucoma	3.91e-05	0.000483	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTM1—glaucoma	3.87e-05	0.000478	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ABCA1—glaucoma	3.83e-05	0.000474	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYP1B1—glaucoma	3.83e-05	0.000474	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EDN1—glaucoma	3.83e-05	0.000474	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NTRK1—glaucoma	3.83e-05	0.000473	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—C3—glaucoma	3.81e-05	0.000471	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—C3—glaucoma	3.69e-05	0.000456	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN2B—glaucoma	3.6e-05	0.000445	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTM1—glaucoma	3.59e-05	0.000443	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NTRK2—glaucoma	3.58e-05	0.000442	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN2B—glaucoma	3.53e-05	0.000436	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EDN1—glaucoma	3.46e-05	0.000427	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SMO—glaucoma	3.43e-05	0.000425	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—MTHFR—glaucoma	3.42e-05	0.000423	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.39e-05	0.000419	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EDN1—glaucoma	3.38e-05	0.000419	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TXN—glaucoma	3.35e-05	0.000415	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—C3—glaucoma	3.35e-05	0.000414	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTM1—glaucoma	3.31e-05	0.000409	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NOS3—glaucoma	3.29e-05	0.000407	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—APOE—glaucoma	3.18e-05	0.000394	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NGF—glaucoma	3.18e-05	0.000393	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—MTHFR—glaucoma	3.17e-05	0.000392	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CAV1—glaucoma	3.15e-05	0.00039	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NTRK2—glaucoma	3.14e-05	0.000388	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NGF—glaucoma	3.11e-05	0.000385	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NGFR—glaucoma	3.07e-05	0.000379	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTM1—glaucoma	3.06e-05	0.000379	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—C3—glaucoma	3.02e-05	0.000373	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.99e-05	0.00037	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—C3—glaucoma	2.96e-05	0.000366	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—APOE—glaucoma	2.95e-05	0.000365	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MTHFR—glaucoma	2.92e-05	0.000362	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CAV1—glaucoma	2.92e-05	0.000361	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NTRK1—glaucoma	2.92e-05	0.000361	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CDKN1B—glaucoma	2.85e-05	0.000353	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOE—glaucoma	2.81e-05	0.000348	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CAV1—glaucoma	2.79e-05	0.000344	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOE—glaucoma	2.75e-05	0.00034	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CAV1—glaucoma	2.73e-05	0.000337	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOE—glaucoma	2.72e-05	0.000337	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MTHFR—glaucoma	2.71e-05	0.000335	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CAV1—glaucoma	2.7e-05	0.000334	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NGFR—glaucoma	2.69e-05	0.000333	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN2B—glaucoma	2.69e-05	0.000332	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FN1—glaucoma	2.65e-05	0.000328	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—glaucoma	2.64e-05	0.000327	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—BAD—glaucoma	2.62e-05	0.000324	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTT1—glaucoma	2.6e-05	0.000322	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FN1—glaucoma	2.6e-05	0.000321	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EDN1—glaucoma	2.58e-05	0.000319	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—BAD—glaucoma	2.57e-05	0.000317	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NTRK1—glaucoma	2.56e-05	0.000317	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOE—glaucoma	2.52e-05	0.000312	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CAV1—glaucoma	2.5e-05	0.000309	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NOS3—glaucoma	2.39e-05	0.000295	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—glaucoma	2.37e-05	0.000293	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NGF—glaucoma	2.37e-05	0.000293	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN2B—glaucoma	2.36e-05	0.000292	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EDN1—glaucoma	2.26e-05	0.00028	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—C3—glaucoma	2.25e-05	0.000279	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NOS3—glaucoma	2.21e-05	0.000273	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—glaucoma	2.18e-05	0.00027	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NOS3—glaucoma	2.11e-05	0.00026	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOE—glaucoma	2.1e-05	0.000259	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NGF—glaucoma	2.08e-05	0.000257	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CAV1—glaucoma	2.08e-05	0.000257	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ABCA1—glaucoma	2.07e-05	0.000256	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP1B1—glaucoma	2.07e-05	0.000256	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NOS3—glaucoma	2.06e-05	0.000255	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NOS3—glaucoma	2.04e-05	0.000252	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—glaucoma	2.02e-05	0.00025	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—C3—glaucoma	1.98e-05	0.000245	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FN1—glaucoma	1.98e-05	0.000245	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BAD—glaucoma	1.95e-05	0.000242	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NOS3—glaucoma	1.89e-05	0.000234	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—glaucoma	1.87e-05	0.000231	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOE—glaucoma	1.84e-05	0.000228	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1B—glaucoma	1.82e-05	0.000226	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CAV1—glaucoma	1.82e-05	0.000226	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—glaucoma	1.79e-05	0.000222	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1B—glaucoma	1.79e-05	0.000221	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FN1—glaucoma	1.74e-05	0.000215	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—glaucoma	1.73e-05	0.000214	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BAD—glaucoma	1.72e-05	0.000212	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—glaucoma	1.69e-05	0.000209	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—glaucoma	1.66e-05	0.000205	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—glaucoma	1.65e-05	0.000205	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NOS3—glaucoma	1.57e-05	0.000194	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—glaucoma	1.52e-05	0.000188	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—glaucoma	1.49e-05	0.000184	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—glaucoma	1.46e-05	0.000181	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOS3—glaucoma	1.38e-05	0.000171	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOE—glaucoma	1.36e-05	0.000169	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1B—glaucoma	1.36e-05	0.000168	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAV1—glaucoma	1.35e-05	0.000167	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—glaucoma	1.26e-05	0.000156	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1B—glaucoma	1.19e-05	0.000148	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—glaucoma	1.15e-05	0.000142	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—glaucoma	1.13e-05	0.00014	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—glaucoma	1.12e-05	0.000139	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—glaucoma	1.11e-05	0.000137	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NOS3—glaucoma	1.02e-05	0.000126	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—glaucoma	9.94e-06	0.000123	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—glaucoma	9.34e-06	0.000115	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—glaucoma	8.55e-06	0.000106	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—glaucoma	7.51e-06	9.28e-05	CbGpPWpGaD
